Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: February 4, 2023

Details for Patent: 6,297,375

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which drugs does patent 6,297,375 protect, and when does it expire?

Patent 6,297,375 protects AKYNZEO and is included in one NDA.

This patent has eighty-one patent family members in fifty-four countries.

Summary for Patent: 6,297,375
Title: 4-phenyl-pyridine derivatives
Abstract:The compounds of the related invention are related to 4-phenyl-pyridine derivatives connected by a bridge containing oxygen or nitrogen to a phenyl derivative.
Inventor(s): Bos; Michael (Montreal, CA), Branca; Quirico (Binningen, CH), Galley; Guido (Rheinfelden, DE), Godel; Thierry (Basel, CH), Hoffmann; Torsten (Birsfelden, CH), Hunkeler; Walter (Magden, CH), Schnider; Patrick (Oberwil, CH), Stadler; Heinz (Rheinfelden, CH)
Assignee: Hoffmann-La Roche Inc. (Nutley, NJ)
Application Number:09/507,456
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 6,297,375

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,297,375

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
99103504Feb 24, 1999
99123689Nov 29, 1999

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.